INTRODUCTION
Monoclonal immunoglobulin (IG) synthesis characterizes monoclonal gammopathies that result from a clonal proliferation of B lymphocytes. The monoclonal component may be directly pathogenic particularly through its high serum concentration, its abnormal structure or its antibody activity leading to several manifestations or affections including tissular deposits most often composed of immunoglobulin light chain subunits. Light chain deposition is responsible for light-chain amyloidosis and light chain deposition disease (LCDD), the term LCDD being restricted to the non-amyloid form of these deposits. LCDD, described by Randall in 1976 is a systemic multivisceral disorder with a 1 , constant renal involvement . Apart from the kidneys, the heart and liver are the most frequently concerned organs . Lung involvement is 2-7 2-7 asymptomatic and usually diagnosed at the time of autopsy by systematic immunofluorescence (IF) study. In 1987, non-amyloid nodular light chain deposits restricted to the lung have been described and recognized as an new LCDD clinicopathological entity . The nodules were 8-13 usually an incidental radiological finding. They may be single or multiple and ranged in size from 0.7 to 4 cm. In 2006, we have reported in three patients a new clinicopathological presentation named cystic lung LCDD . The patients had dyspnea and numerous cysts distributed in 14 both lungs on the CT scan. Unlike systemic LCDD, they progressively developed end-stage respiratory failure requiring lung transplantation. Lung transplantation was bilateral in all cases. Moreover, none of the patients had renal disturbances and the origin of light chain production was not found by bone marrow biopsy and aspiration. Histological examination of the lung explant specimens showed diffuse parenchymal non-amyloid monoclonal light chain deposits associated with numerous cysts and a mild lymphoplasmacytic infiltrate. Despite the lack of Patients (see ) Table 1 Among the 572 patients who underwent lung transplantation at Beaujon (Clichy) and Foch (Suresnes) Hospitals, France, 36 had a pulmonary cystic disorder. Of them, three fulfilled the diagnostic criteria of cystic lung LCDD . The diagnosis of LCDD was made before 14 lung transplantation in only one patient (patient 2) on a surgical lung biopsy. For the two other patients, it was established on the explanted lungs.
Diagnosis of LCDD
Histological examination of lung specimens showed similar lesions that has been previously described . Briefly, the main finding was 14 the presence of non-amyloid amorphous eosinophilic deposits composed of monotypic light chains widely infiltrating alveolar walls, small κ airways and vessels. Congo red did not show apple-green birefringence under polarized light and electron microscopy revealed granular electron-dense deposits, thus excluding amyloidosis. The k light chain nature of the deposits was determined by immunofluorescence study on frozen tissue sections. , IgG, IgA and IgM were not detected. The deposits were surrounded by macrophagic giant cells and were associated λ with cystic lung destruction characterized by emphysematous-like changes and marked bronchiolar dilatation. Only small preserved lung areas were found. A mild lymphoplasmacytic infiltrate was present in the lung parenchyma and is further characterized in the present study.
Clinical presentation
Clinical characteristics of the patients are given in . Two of them (patients 1 and 2) have already been reported . Briefly, the Table 1 14 patients presented with a progressive obstructive dyspnea and numerous cysts diffusely distributed in both lungs on the CT scan. In one of them, small bilateral hilar lymphadenopathies appeared during the follow-up (patient 1). End-stage respiratory failure reached over a period from 3 to 10 years required lung transplantation which was bilateral in all cases. Before lung transplantation, one patient (patient 2) underwent high dose chemotherapy followed by autologous blood stem cell transplantation as proposed in severe systemic LCDD. However the disease persisted with worsening of dyspnea and dramatic increase in the number of cysts. Table 1 In the serum, only a free monoclonal light chain was detected in one patient (patient 1). Bone marrow biopsy and bone marrow aspiration κ did not show increase in the number of plasma cells or lymphocytes. Moreover, plasma cells did not show cytological abnormalities and the / κ λ ratio was preserved. Table 1 Investigations for systemic extension of the disease especially including renal, liver and heart investigations, only revealed monotypic κ light chain deposits in the salivary glands of patients 2 and 3.
Hematological characteristics ( )

Systemic extension of the disease ( )
Outcome
The free light chain present before lung transplantation in patient 1 was no more identified 3 months after the procedure. The three κ patients are still alive without recurrence of the disease 47 months (range: 33 to 69 months) after lung transplantation.
Histological and immunohistochemical evaluation of the lymphoplasmacytic infiltrate
Explanted Lung tissue was taken from the upper, middle and lower lobes. Hilar and lobar lymph nodes were also sampled at time of transplantation. At least 20 paraffin-embedded tissue blocks were available for each case as well as 3 lung frozen samples. Immunophenotyping of the lymphoid population was performed on paraffin-embedded contiguous sections on Ventana Benchmark automated immunostainer with commercial primary antibodies directed against CD20 (Dako, Denmark, clone L26, 1/500), CDS (Novocastra, 
DNA extraction and clonality analysis
DNA was obtained by a standard proteinase K digestion and a phenol-chloroform extraction of lung explant specimens, regional lymph nodes and post-lung transplant peripheral blood samples after isolation of mononuclear cells on Ficoll gradient. When extracted from tissue samples, DNA was submitted to a quality control: DNA was amplified using a multiplex PCR generating 100/200/300/400 and 600 base pairs PCR fragments as reported . The DNA quality was scored as good when 4 or 5 bands were obtained, correct when 3 bands were obtained 15 and insufficient for full clonality analysis when less than 3 bands were obtained. For immunoglobulin heavy chain gene rearrangement study, the two PCR FR1 and FR2 were performed according to BIOMED-2 protocol . The third PCR, FR3, was done as previously described . products, the interpretation of PCR results was, as expected, directly related to the maximum size amplified by the sample in the control gene PCR. For heavy chain CDR3 length diversity analysis, the amplified products were run on an ABI prism 3100 genetic Analyzer (Applied Biosystems). Results were analyzed using Genscan analysis software (Applied Biosystems). Samples with a unique dominant peak within the polyclonal background were considered as clonal and the clonal population was characterized by its heavy chain CDR3 size. The B-cell repertoire pattern in pulmonary tissue sample was compared with that in blood sample and in hilar lymph node tissue sample when available. In a patient, two dominant B-cell populations were considered identical when they displayed the same heavy chain CDR3 size. For kappa light chain gene rearrangement analysis, BIOMED-2 protocol was used, and PCR products were electrophoresed in an 8 polyacrylamide gel after % heteroduplex formation.15
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As recommended by the French governmental Agence Nationale d Accr ditation et d Evaluation en Sant (ANAES) in its
Recommendations for cryopreserved cell and tissue libraries for molecular analyses patients were informed that part of the specimens could be 
Sequence analysis
For nucleotide sequence analysis, PCR products were directly sequenced (for Heavy chain genes sequencing) or strong dominant PCR products were extracted from 6 polyacrylamide gel by elution (for Light chain genes sequencing). Big Dye Terminator cycle sequencing % reaction kit (Applied Biosystems) was used prior to electrophoresis on an automated sequencer (ABI PRISM 3130XL, Applied Biosystems). The sequences were aligned to Immunoglobulin sequences using IMGT/V-QUEST and IMGT/JunctionAnalysis , from IMGT , the 18 19 ® international ImMunoGeneTics information system ( ; founder and director Marie-Paule Lefranc, Montpellier, France ). ® http://imgt.cines.fr 20 IGHV/IGHD/IGHJ or IGKV/IGKJ usage was determined and the heavy or light CDR3 were identified. Somatic mutations were defined as nucleotide substitutions after elimination of the known polymorphisms described in IMGT . The ability to code for functional chains was ® determined by translating DNA sequences into amino acids.
FISH studies
Interphase fluorescence in situ hybridization (FISH) analyses were performed on formalin-fixed paraffin embedded tissue sections from lung tissue specimens using split-signal DNA probes for (Dako, SA, Glostrup, Denmark) according to the manufacturer s MALT1 '
recommendations (
). www.euro-fish.org
RESULTS
Non-amyloid monotypic kappa light chain deposits are associated with a lymphoplasmacytic infiltrate
The density of the lymphoplasmacytic infiltrate was variable among the 3 patients but remained mild and non destructive in all cases. Very scarce lymphoid aggregates were present along the bronchovascular bundles in patients 2 and 3 while lymphoid aggregates were more numerous in patient 1 ( ). Rare lymphoid aggregates displayed features reminiscent of lymphoid follicles with atrophic germinal Figure 1A centres. Cytologically. the lymphoid cells were small, with scanty cytoplasm, round nuclei and mild plasmacytoid differentiation. There was no large cell component. Immunohistochemical analysis showed that the lymphoid cells displayed a CD20 . CD5 . CD10 . Bcl2 . CD23 . IgD- lymphocytes were labeled by anti-Ki-67 antibody ( ). In addition, scattered mature plasma cells expressing CD138 were observed Figure 1D around the lymphoid aggregates ( ), or at distance admixed with light chain deposition. Immunofluorescence analysis with and , Figure 1E κ λ light chain antibodies of this plasma cell component did not show any light chain restriction ( ). Figure 1F The hilar and lobar lymph node architecture was preserved. The cortex and medulla were infiltrated by some light chain deposits and a κ mild plasma cell infiltrate without cytological abnormalities. and light chains were equally expressed by the plasma cells. Finally, the pulmonary, nodal and salivary gland infiltrate did not exhibit the characteristic morphological criteria of MALT lymphoma, i.e. hyperplastic reactive lymphoid follicles, expansion of the marginal zone by centrocyte-like tumor cells and lymphoepithelial lesions. The pulmonary lymphoid infiltrate was reminiscent of bronchus-associated lymphoid tissue (BALT) . 21
All three patients present a lung monoclonal B cell population
DNAs extracted from biopsies were analyzed for their amplificability. Indeed, poor DNA quality could lead to false-positive results due to misinterpretation of pseudoclonality . All DNA has excellent or correct quality control in agreement with data currently observed from 15 frozen or formalin-fixed samples . 15
A dominant B-cell clone was identified in the lung tissue of the three patients. According to the DNA quality, the dominant clone was detected with FR1, FR2 and FR3 PCR (patients 1 and 3, see ) or by one PCR (FR2) for patient 2. As shown in , this B cell figure 2A figure 2 clone was largely predominant when compared to the surrounding normal B cells. For patients 1 and 3, hilar lymph nodes could be analyzed. In each case, a faint dominant B-cell clone was found. It was identical to the pulmonary dominant clone ( ). figure 2B Post-lung transplant peripheral blood B-cell repertoire was polyclonal in patients 2 and 3 ( ). Because neither lung transplantation Figure 2C nor immunosuppressive associated therapy are supposed to cure a leukemic form of small B-cell lymphoproliferative disorder, we conclude that lung clonal B cell detection was not related to contaminant circulating tumoral cells. In patient 1, peripheral blood B-cell repertoire analysis was not conclusive because of deep B lymphocyte depletion.
All three clonal populations carry an unmutated IGHV4-34/IGKV1 stereotyped receptor
To further characterize these clonal populations we decided to sequence the IGH clonal rearrangement to look for somatic mutations, an indirect criteria for antigen driven B-cell expansion . As expected from Genscan analysis, a clear dominant sequence was obtained by direct 22 sequencing of PCR products (data not shown). Patients shared a common IGHV4-34 01 and IGHJ4 02 gene usage. IGHD4 23 01 gene was * * -* also common to patients 2 and 3 (
). Interestingly, no deletion of the 3 V-region, no N1 region was observed in the three patients. The Figure 3 A ′ N2 region was restricted to two nucleotides (patients 1 and 3) and was absent in patient 2. However, although the N diversity was restricted, it clearly differed between patients, avoiding PCR contamination. Surprisingly, all three IGVH genes were found unmutated.
Nucleotide sequence translation revealed not only an uncommon short 9 amino acid heavy chain CDR3 length but also an only one amino acid divergence between patients ( ). It is interesting to note in patient 3, the usage of a different IGHD gene (IGHD5 12 01, instead 
The pulmonary lymphoid infiltrate did not show rearrangement of the MALT1 gene
Using FISH analysis, we did not find any rearrangement of the MALT1 gene, a chromosomal alteration commonly observed in pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma . 26
DISCUSSION
Pulmonary non-amyloid light chain deposits occur in the three following forms of LCDD: the systemic multivisceral form, the pulmonary nodular form and, as we recently suggested, the pulmonary cystic form. The current study demonstrates that cystic lung LCDD clearly differs from the two other forms by clinical and molecular features ( ). Table 2 Cystic lung LCDD is a rare disorder , mostly arising in young females. They had dyspnea associated with an obstructive pattern and 14 numerous cysts distributed in both lung fields on the CT scan. The number of cysts progressively increased with a concomitant worsening of dyspnea that required lung transplantation after a few years. Thirty-three to 69 months after bilateral lung transplantation, the patients are in good condition without recurrence of the disease. These clinical findings show that lung involvement in cystic lung LCDD threatens patient s ' life as opposed to what is observed in systemic LCDD and nodular lung LCDD. Moreover, patients affected by cystic lung LCDD are 25 years younger than the others 2 13 . Besides the age of patients and pulmonary manifestations, cystic lung LCDD may be clinically distinguished [ -] from the systemic multivisceral form by the absence of renal involvement and of relapse after adequate organ transplantation . 27
In the systemic form of LCDD, monoclonal light chains deposited in the target organs are produced by a bone marrow clonal plasma cell proliferation as seen in monoclonal gammopathy of undetermined significance or multiple myeloma diagnosed in 17 and 58 of cases, % % respectively . At the opposite, in the pulmonary nodular form of LCDD, monoclonal light chain synthesis seems to be a localized process 3 8-. A diagnosis of primary pulmonary low grade B cell lymphoma (MALT lymphoma and lymphoplasmacytic lymphoma) or lung 13 plasmocytoma was made in five of the ten patients reported in the literature. In the present study, bone marrow aspiration and biopsy were normal (plasma cells <5 , preserved / ratio). Although the pulmonary lymphoid infiltrate associated with light chain deposits was % κ λ κ morphologically and immunophenotypically more suggestive of BALT than B cell neoplasm, we looked for clonality of pulmonary B cells. We hypothesized that monoclonal light chain synthesis occurred in the lung in view of the absence of recurrence of the disease after bilateral lung transplantation and of the normalization of serum free light chains / ratio after the procedure. PCR clonality analysis disclosed a predominant κ λ B cell clone in the lung of our three patients. In two of them, the same clonal expansion with a lower fluorescence signal was detected in the hilar or lobar lymph nodes. In order to exclude a tissular infiltration by a circulating disorder, we performed peripheral blood clonality analysis. It was done after lung transplantation but we assumed that a small B cell extrapulmonary lymphoproliferative disorder would not be cured by lung transplantation or by immunosuppressive treatment. Peripheral blood revealed a polyclonal pattern. According to the trafficking of antibody secreting cells and by analogy with non-disseminated pulmonary MALT lymphoma , we postulate that involvement of regional 28 29 lymph nodes and distant spread to other mucosal sites in cystic lung LCDD might be related to the peculiar expression of specific adhesion molecules and chemokine receptors by the clonal cells and did not correspond to a metastatic process. Although the morphological features observed in our study do not met the histological diagnosis criteria of MALT lymphoma as requested in the WHO lymphoma classification , 30 we can not exclude that these cases may be part of the morphological spectrum of pulmonary MALT lymphomas.
While it is currently acknowledged in systemic multivisceral LCDD that light chains exhibit a number of somatic mutations and/or posttraductional modifications conferring new properties to light chain protein, no study has been yet concerned with potential distinctive heavy chain features. Remarkably, we showed that the B cell clones from our three patients expressed homologous IGHV/IGKV repertoire for IG rearrangement using the IGHV4-34 01/IGKV1 subgroups. The usage of a IGHV4-34/IGKV1 stereotyped receptor with closely homologous proliferation of B cells with particular surface IG. However, the causal antigens remain to be identified. Stereotyped B cell antigen receptors were also found in subsets of marginal zone lymphomas arising in the lymph nodes , and in MALT mucosa-associated lymphoid tissue , 36 37 23 . 38 In marginal zone lymphomas, the possibility of antigen-driven lymphomagenesis has been demonstrated. The risk for developing MALT lymphoma is severely increased in patients with chronic antigenic stimulation by autoantigens and/or microbial pathogens. Chronic stimulation of the immune system induces a sustained lymphoid proliferation favoring the neoplastic transformation process . Sj gren syndrome and 39 ö 40 autoimmune Hashimoto thyroiditis are the most frequent underlying autoimmune conditions. The list of microbial species involved in the 41 development of lymphoproliferations has progressively grown and now comprises 5 distinct members: Helicobacter pylori, Campylobacter and hepatitis C virus (HCV), which have been associated with MALT gastric lymphoma, jejuni, Borrelia burgdorferi, Chlamydia psittaci immunoproliferative small intestinal disease (IPSID), MALT cutaneous lymphoma, MALT ocular lymphoma, and marginal zone spleen lymphoma, respectively. All these variants of lymphoma have the same immunophenotypical features except IPSID. The malignant cells of IPSID secrete a monotypic truncated Ig -heavy chain lacking an associated light chain . This fact in addition to the notion of persistent HCV lead to regression of the lymphoma . Therefore, the evidence that our study provides clues for a putative common antigen in cystic 47 lung LCDD is of great interest. In our patients, the search for serum anti-HCV antibodies was negative. To address the issue of the implication of bacterial respiratory infection promoting B cell clonal expansion in cystic lung LCDD, we performed PCR amplification using universal bacterial 16S rDNA primers and templates prepared from frozen lung tissue (data not shown). No pulmonary bacterial infection could be detected. These are preliminary data that require further investigations. In conclusion, because the patients shared unique clinical, histological and molecular features, we propose that cystic lung LCDD should be considered as a distinct entity. Moreover, we show that the different pulmonary B cell clones use a IGHV4-34/IGKV1 stereotyped receptor, a molecular data strongly arguing for an antigen-driven primary pulmonary lymphoproliferation. Our results could have an important therapeutic implication since bilateral lung transplantation seems to be the only current valid therapeutic option. 
FIGURE 2
Genscan analysis of PCR products Amplifications of immunoglobulin heavy chain CDR3 sequences were performed using the three FR1, FR2, FR3 primer sets. PCR products were run on a sequence analyzer and sizes were determined using a size marker (in red) and the Genscan software. The figure shows representative data in patient 1 of (A) the dominant clone detected in the lung, (B) the PCR product alignment of lung and lymph node dominant clone, and (C) the comparison of lung clone and polyclonal blood B cell repertoire.
FIGURE 3
Alignment of nucleotide sequences and translation of IG heavy chain CDR3 DNA extracted from lung explant specimens was amplified using the FR1/JH BIOMED-2 PCR protocol. After purification, PCR fragments were directly sequenced.
Sequences were aligned to Immunoglobulin sequences using IMGT/V-QUEST and IMGT/JunctionAnalysis , from A: 18 19 IMGT the international ImMunoGeneTics information system (http//imgt.cines.fr). Somatic mutations were defined as nucleotide substitutions 
